AbbVie Inc. (ABBV)

NYSE: ABBV · Real-Time Price · USD

206.23

-2.11 (-1.01%)

At close: Mar 19, 2026, 4:00 PM EDT

206.65

+0.42 (0.20%)

After-hours: Mar 19, 2026, 4:10 PM EDT

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Quarter	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020
Period Ending	Dec '25 Dec 31, 2025	Sep '25 Sep 30, 2025	Jun '25 Jun 30, 2025	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Sep '24 Sep 30, 2024	Jun '24 Jun 30, 2024	Mar '24 Mar 31, 2024	Dec '23 Dec 31, 2023	Sep '23 Sep 30, 2023	Jun '23 Jun 30, 2023	Mar '23 Mar 31, 2023	Dec '22 Dec 31, 2022	Sep '22 Sep 30, 2022	Jun '22 Jun 30, 2022	Mar '22 Mar 31, 2022	Dec '21 Dec 31, 2021	Sep '21 Sep 30, 2021	Jun '21 Jun 30, 2021	Mar '21 Mar 31, 2021	Dec '20 Dec 31, 2020	Sep '20 Sep 30, 2020	Jun '20 Jun 30, 2020	Mar '20 Mar 31, 2020
United States Revenue	12.79B
United States Revenue Growth	9.03%
International Revenue	3.82B
International Revenue Growth	13.54%
Revenue (Total)	16.62B
Revenue (Total) Growth	10.04%

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Quarter	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020
Period Ending	Dec '25 Dec 31, 2025	Sep '25 Sep 30, 2025	Jun '25 Jun 30, 2025	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Sep '24 Sep 30, 2024	Jun '24 Jun 30, 2024	Mar '24 Mar 31, 2024	Dec '23 Dec 31, 2023	Sep '23 Sep 30, 2023	Jun '23 Jun 30, 2023	Mar '23 Mar 31, 2023	Dec '22 Dec 31, 2022	Sep '22 Sep 30, 2022	Jun '22 Jun 30, 2022	Mar '22 Mar 31, 2022	Dec '21 Dec 31, 2021	Sep '21 Sep 30, 2021	Jun '21 Jun 30, 2021	Mar '21 Mar 31, 2021	Dec '20 Dec 31, 2020	Sep '20 Sep 30, 2020	Jun '20 Jun 30, 2020	Mar '20 Mar 31, 2020
Immunology Revenue	8.63B
Immunology Revenue Growth	18.26%
Neuroscience Revenue	2.96B
Neuroscience Revenue Growth	18.02%
Oncology Revenue	1.66B
Oncology Revenue Growth	-1.60%
Aesthetics Revenue	1.29B
Aesthetics Revenue Growth	-0.92%
Eye Care Revenue	580.00M
Eye Care Revenue Growth	-10.22%
Other Key Products Revenue	884.00M
Other Key Products Revenue Growth	-3.07%
All Other Revenue	617.00M
All Other Revenue Growth	-17.95%
Revenue (Total)	16.62B
Revenue (Total) Growth	10.04%

Updated Feb 4, 2026. Data Source: Fiscal.ai.